Product
SASS
1 clinical trial
1 indication
Indication
Epidermolysis Bullosa DystrophicaClinical trial
SASS 3: Self-Assembled Skin Substitute (SASS) for the Treatment of Epidermolysis BullosaStatus: Active (not recruiting), Estimated PCD: 2019-12-24